Cleveland Clinic Neurology Update A Comprehensive Review for the Clinician 2026
Clinical Neurology Review • Stroke • Epilepsy • Multiple Sclerosis • Dementia • Headache • Neuromuscular Disorders • Neuroradiology
Cleveland Clinic Neurology Update A Comprehensive Review for the Clinician 2026 brings together clinically focused education across a broad range of neurological conditions. Presented by the Cleveland Clinic Neurological Institute, the 17th Annual Neurology Update combines diagnostic and therapeutic updates with case-based learning for clinicians involved in neurological care. The original conference dates were August 7–9, 2026, with an in-person venue at The Ritz-Carlton, Washington, D.C., alongside a virtual attendance option. Cleveland Clinic
The curriculum connects established areas of neurological practice—stroke, epilepsy, multiple sclerosis, dementia, headache, and Parkinson’s disease—with focused reviews of genetic testing, neuroinfectious diseases, brain incidentalomas, tumor suppressor syndromes, neuromuscular conditions, and sleep technology. Its emphasis is on clinically applicable knowledge and the interpretation of neurological problems through individual cases. Cleveland Clinic
Course Details
| Detail | Information |
|---|---|
| Product Title | Cleveland Clinic Neurology Update A Comprehensive Review for the Clinician 2026 |
| Official Activity Name | 2026 Neurology Update: A Comprehensive Review for the Clinician |
| Annual Meeting | 17th Annual Cleveland Clinic Neurology Update |
| Presenting Institute | Cleveland Clinic Neurological Institute |
| Original Conference Dates | August 7–9, 2026 |
| Original Program Duration | Three days |
| Original Meeting Format | Hybrid: in-person and virtual participation |
| In-Person Venue | The Ritz-Carlton, Washington, D.C. |
| Primary Educational Focus | Clinical evaluation and management of neurological disorders |
| Course Co-Directors | Glen Stevens, DO, PhD, FAAN; Robert Marquardt, DO |
These details describe the original Cleveland Clinic educational activity, rather than the file inventory or access arrangements of a separate digital product. Cleveland Clinic
Target Audience
This course is directed towards neurologists, internists and family practice physicians, advanced practice providers including PAs and APRNs, nurses and others involved in the diagnosis and treatment of neurological disorders. Cleveland Clinic
The broad clinical scope may also make it useful as supplementary learning for neurology residents and fellows, hospitalists, and educators reviewing neurological care. Its principal focus is a clinical neurology update, rather than a dedicated examination question bank.
Program Overview
The program combines presentations across neurological subspecialties with opportunities to apply knowledge to clinical scenarios. Alongside the general sessions, the original meeting incorporated smaller, case-based breakouts addressing headache, dementia, and Parkinson’s disease, with a rotation designed to allow participants to experience each topic. Cleveland Clinic
The original educational format also included question-and-answer discussions and audience-response polling. These activities were intended to encourage participation and self-assessment, allowing attendees to compare their clinical reasoning with that of their peers. These interactive elements describe the original conference experience and should not be assumed to accompany separately supplied study materials. Cleveland Clinic
Learning Objectives
Upon completion of this activity, the participant will be able to:
- Discuss updated strategies for acute stroke prevention and treatment.
- Review updated diagnostic criteria and cases for the management of multiple sclerosis.
- Discuss advances in epilepsy management for various clinical settings and demographics.
- Outline current clinical strategies in the management of dementia, neuroinfectious diseases, headache, tumor suppressor syndromes, and Parkinson’s disease.
- Describe recent technological innovations and established best practices in neuroradiology through specific techniques and individual case studies.
- Review recent research and updates on neuromuscular conditions, including myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), and peripheral nerve injuries.
- Discuss the use of genetics in the diagnosis, management, and treatment of neurological disorders.
- Outline the use of technology in the diagnosis and treatment of sleep disorders.
These are the objectives supplied in your source text and reproduced in Cleveland Clinic’s official overview. Cleveland Clinic
Featured Topics
| Brain Incidentalomas | Dementia | Epilepsy |
| Genetic Testing | Headache Cases | Multiple Sclerosis |
| Myasthenia Gravis | Neuroinfectious Diseases | Neuroradiology |
| Parkinson’s Disease | Peripheral Nerve Injury | Polyneuropathy and CIDP |
| Tumor Suppressor Syndromes in Neurology | Sleep and Technology | Stroke |
The featured-topic list follows the original program’s stated scope. Cleveland Clinic
Official Program Overview by Day
Friday, August 7, 2026
| Session Focus | Faculty |
|---|---|
| Cerebrovascular care update | A. Blake Buletko |
| Clinical stroke cases | A. Blake Buletko |
| Neurological genetic panels and testing | Angelika Erwin |
| Acute symptomatic seizures: outcomes and management | Vineet Punia |
| Managing epilepsy beginning in older adulthood | Vineet Punia |
| Multiple sclerosis update | Alise Carlson |
| Case-based multiple sclerosis management | Alise Carlson |
| Neuro Jeopardy and AAN developments | Glen Stevens and Robert Marquardt |
Friday also included a dedicated multiple sclerosis question-and-answer session. Cleveland Clinic
Saturday, August 8, 2026
| Session Focus | Faculty |
|---|---|
| Headache case discussions | Madisen Olson |
| Dementia case discussions | Nicholas Doher |
| Parkinson’s disease case discussions | Hubert Fernandez |
| Myasthenia gravis treatment update | Benjamin Claytor |
| Polyneuropathy and CIDP: treatment advances | Benjamin Claytor |
| Neuroinfectious diseases | Carlos Isada |
| Neurological tumor-suppressor syndromes: developing therapies and comprehensive care | Mina Lobbous |
The three rotating case-based breakouts were followed by audience-response discussion and questions. Cleveland Clinic
Sunday, August 9, 2026
| Session Focus | Faculty |
|---|---|
| Spinal neuroradiology | Jenny Wu |
| Brain neuroradiology | Jenny Wu |
| Brain incidentalomas | Tara Miller |
| Managing epilepsy in women | Susan Stanton |
| Peripheral nerve injury | Megan Jack |
| Sleep and technology | Brian Chen |
Historical vignettes and faculty panel discussions were scheduled across all three days. Cleveland Clinic
Course Directors and Faculty
Course Co-Directors
Glen Stevens, DO, PhD, FAAN
Adult Neuro-Oncology, Cleveland Clinic Neurological Institute.
Robert Marquardt, DO
Neuromuscular Center, Cleveland Clinic Neurological Institute. Cleveland Clinic
Cleveland Clinic Faculty
| Faculty | Faculty |
|---|---|
| A. Blake Buletko, MD | Alise Carlson, MD, MSc |
| Brian Chen, MD | Benjamin Claytor, MD |
| Nicholas Doher, DO | Angelika Erwin, MD, PhD |
| Hubert H. Fernandez, MD | Carlos Isada, MD |
| Megan Jack, MD, PhD | Mina Lobbous, MD, MPH |
| Tara Miller, MSN, APRN-CNP | Madisen Olson, DO, MBA |
| Vineet Punia, MD, MS | Susan Stanton, PA-C, MS, MSHS |
| Jenny Wu, MD |
Planning Committee: Glen Stevens, DO, PhD, FAAN; Robert Marquardt, DO; Tara Miller, MSN, APRN-CNP; and Susan Stanton, PA-C, MS, MSHS. Cleveland Clinic
Major Topics Covered
Stroke, Epilepsy, and Multiple Sclerosis
These core areas connect neurological diagnosis with clinical management. The learning objectives address stroke prevention and treatment, advances in epilepsy management across different clinical settings and patient populations, and the application of updated multiple sclerosis diagnostic criteria to clinical cases. Together, they provide a framework for reviewing major neurological conditions encountered in practice. Cleveland Clinic
Dementia, Headache, and Parkinson’s Disease
The case-based component focuses on translating clinical knowledge into decisions about individual patients. Dementia, headache, and Parkinson’s disease receive dedicated attention within the breakout format, complementing the wider curriculum with opportunities to consider presentations, diagnostic reasoning, and management approaches. Cleveland Clinic
Neuromuscular Disorders and Peripheral Nerve Injury
The neuromuscular curriculum includes myasthenia gravis, polyneuropathy, chronic inflammatory demyelinating polyneuropathy, and peripheral nerve injury. The stated objectives emphasize research updates and clinical approaches to these conditions, making this a defined component of the course rather than an incidental part of the general review. Cleveland Clinic
Neuroimaging, Genetics, Neuroinfection, and Sleep
The program broadens the review through neuroradiology, brain incidentalomas, genetic testing, tumor suppressor syndromes, and neuroinfectious diseases. It also considers technological applications in the diagnosis and treatment of sleep disorders. These areas complement the disease-focused sessions by examining additional diagnostic tools, clinical contexts, and approaches to neurological care. Cleveland Clinic
Why This Course Is Relevant
For clinicians seeking a comprehensive neurology review, the course offers breadth without limiting the curriculum to a single subspecialty. Its educational approach combines neurological disease updates with case-based discussion, encouraging learners to connect diagnostic information with management decisions. Cleveland Clinic
The program may be particularly useful for organizing a personal review of neurological practice: identifying areas that need refreshing, revisiting clinical reasoning, and considering how developments across different subspecialties relate to the patients a clinician sees.
Original Conference Accreditation
Cleveland Clinic’s published information designates the original live activity for up to 17 AMA PRA Category 1 Credits™, 17 ANCC contact hours, 17 AAPA Category 1 CME credits, and 17 IPCE credits. The nursing allocation includes 4 APRN pharmacology contact hours. The activity was also approved by the American Board of Psychiatry and Neurology as part of a comprehensive self-assessment CME activity. Cleveland Clinic
These designations apply to the original Cleveland Clinic activity. They do not establish CME eligibility, a certificate entitlement, or access to the original self-assessment process through a separate MedicalAmboss purchase.
Related Learning on MedicalAmboss
For additional neurological study, explore the Neurology / neurosurgery courses collection. The Radiology collection provides a separate route for browsing imaging-focused educational resources. Medical Amboss
Product-Specific Verification Note
The curriculum above is verified against Cleveland Clinic’s official program. The MedicalAmboss package’s recording count, total running time, included file formats, delivery terms, and completeness have not been independently confirmed.
The published agenda does not identify dedicated EEG, EMG, laboratory-interpretation, or surgical-technique modules. Those items should therefore not be advertised as separately included sessions without checking the actual materials. Cleveland Clinic
Short Description
<div style="border:2px solid #1677b8;border-left:6px solid #1677b8;border-radius:10px;padding:16px;background:#f7fbfe;color:#17324d;line-height:1.65;">
<p style="margin:0 0 12px;">
<strong>Cleveland Clinic Neurology Update A Comprehensive Review for the Clinician 2026</strong>
offers a clinically focused review of stroke, epilepsy, multiple sclerosis,
dementia, headache, Parkinson’s disease, neuromuscular disorders,
neuroinfectious diseases, genetic testing, neuroradiology, and sleep technology.
The original program combines clinical updates with case-based learning.
</p>
<p style="margin:0 0 12px;">
<strong>Designed for:</strong> Neurologists, internists, family practice
physicians, PAs, APRNs, nurses, and other professionals involved in
neurological diagnosis and treatment.
</p>
<p style="margin:0;">
<strong>Important:</strong> Original conference accreditation and live
interactive activities are separate from any MedicalAmboss purchase.
</p>
</div>
+ Topics:
FRIDAY, AUGUST 7, 2026
|
|
|
7:00 am
|
Registration/Continental Breakfast/Exhibits/Self-Assessment Online Pre-Test |
|
8:00 am
|
Introduction SALON I: Glen Stevens & Robert Marquardt |
|
8:10 am
|
Updates in Cerebrovascular Care* A. Blake Buletko |
|
8:50 am
|
Stroke Cases* A. Blake Buletko |
|
9:30 am
|
Genetic Testing and Panels for Neurological Disorders Angelika Erwin |
|
10:10 am
|
Refreshment Break & Exhibits SALON II |
|
10:30 am
|
Acute Symptomatic Seizures: Management and Outcomes* Vineet Punia |
|
11:10 am
|
New-onset Epilepsy Management in Older Adults* Vineet Punia |
|
11:50 am
|
Historical Vignette and Panel Discussion / Q&A Glen Stevens, Robert Marquardt, A. Blake Buletko, Angelika Erwin and Vineet Punia |
|
12:20 pm
|
Buffet Lunch SALON II |
|
1:20 pm
|
Update on Multiple Sclerosis* Alise Carlson |
|
2:00 pm
|
Multiple Sclerosis Management Cases* Alise Carlson |
|
2:40 pm
|
Multiple Sclerosis Q&A Alise Carlson |
|
2:55 pm
|
Refreshment Break & Exhibits SALON II |
|
3:15 pm
|
Neuro Jeopardy / AAN Updates* Glen Stevens and Robert Marquardt |
|
4:15 pm
|
Adjourn |
SATURDAY, AUGUST 8, 2026
|
|
|
7:30 am
|
Registration/Continental Breakfast/Exhibits |
| Interactive Case-based Breakout Sessions In-person attendees will be assigned to a room and the speakers will rotate through discussing each topic below. TOPICS:Headache Cases*: Madisen Olson |
|
|
8:00 am
|
Breakout Session Introductions: General Session Room SALON I Robert Marquardt |
|
8:10 am
|
Breakout Session 1: Salon I, Plaza I, Plaza II |
|
9:10 am
|
Breakout Session 2: Salon I, Plaza I, Plaza II |
|
10:10 am
|
Refreshment Break SALON II |
|
10:30 am
|
Breakout Session 3: Salon I, Plaza I, Plaza II |
|
11:30 am
|
Audience Response / Questions & Answers from Breakout Sessions SALON I – Madisen Olson, Nicholas Doher and Hubert Fernandez |
|
12:00 pm
|
Buffet Lunch SALON II |
|
1:00 pm
|
Update on Myasthenia Gravis Treatment* Benjamin Claytor |
|
1:40 pm
|
New Treatments for Polyneuropathy and CIDP* Benjamin Claytor |
|
2:20 pm
|
Refreshment Break & Exhibits SALON II |
|
2:40 pm
|
Neuroinfectious Diseases* Carlos Isada |
|
3:20 pm
|
Tumor Suppressor Syndromes in Neurology, Therapeutic Development and Comprehensive Care Models* Mina Lobbous |
|
4:00 pm
|
Historical Vignette and Panel Discussion / Q&A Glen Stevens, Robert Marquardt, Benjamin Claytor, Carlos Isada and Mina Lobbous |
|
4:20 pm
|
Adjourn |
SUNDAY, AUGUST 9, 2026
|
|
|
7:30 am
|
Registration/Continental Breakfast/Exhibits |
|
8:00 am
|
Neuroradiology – Spine Jenny Wu |
|
8:40 am
|
Neuroradiology – Brain* Jenny Wu |
|
9:20 am
|
Brain Incidentalomas Tara Miller |
|
9:40 am
|
Epilepsy Management for Women* Susan Stanton |
|
10:00 am
|
Refreshment Break SALON II |
|
10:20 am
|
Peripheral Nerve Injury Megan Jack |
|
11:00 am
|
Sleep and Technology Brian Chen |
|
11:40 am
|
Historical Vignette and Panel Discussion / Q&A Glen Stevens, Robert Marquardt, Jenny Wu, Tara Miller, Susan Stanton, Megan Jack and Brian Chen |
|
12:00 pm
|
Adjourn |



